OverviewChartTechnicalNewsTraderScreen

APTOSE BIOSCIENCES INC/  CA03835T3091  /

Toronto
2024-05-02  9:51:58 PM Chg. -0.01 Volume Bid10:00:23 PM Ask10:00:23 PM High Low
1.65CAD -0.60% 3,109
Turnover: 5,133		 1.64Bid Size: 1,500 1.70Ask Size: 3,000 1.67 1.64
GlobeNewswire 03-26 Aptose Reports Results for the Fourth Quarter and Full Year 2023
GlobeNewswire 03-18 Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on ...
GlobeNewswire 01-31 Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement...
GlobeNewswire 01-26 Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placeme...
GlobeNewswire 2023-12-10 Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
GlobeNewswire 2023-11-30 Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role
GlobeNewswire 2023-11-09 Aptose Reports Results for the Third Quarter 2023
GlobeNewswire 2023-11-02 Aptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meeting
GlobeNewswire 2023-10-30 Aptose Presents Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug ...
GlobeNewswire 2023-10-26 Aptose to Report Third Quarter 2023 Financial Results and Hold Conference Call on Thursday, November...
GlobeNewswire 2023-10-23 Aptose to Hold Clinical Update and KOL Data Review of AML Drug Tuspetinib on Monday, October 30th
GlobeNewswire 2023-10-16 Aptose Clinical and Preclinical Data to be Presented at European School of Haematology (ESH) 6th Int...
GlobeNewswire 2023-09-18 Aptose to Present at the Cantor Global Healthcare Conference
GlobeNewswire 2023-09-06 Aptose Announces Closing of $3 Million Investment by Hanmi Pharmaceutical
GlobeNewswire 2023-08-24 Aptose to Present at the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewswire 2022-03-22 Aptose Reports Results for the Fourth Quarter and Full Year 2021
GlobeNewswire 2022-03-08 Aptose to Report Fourth Quarter and Full Year 2021 Financial Results and Hold Conference Call on Tue...
GlobeNewswire 2022-03-01 Aptose to Present at Oppenheimer’s 32nd Annual Healthcare Conference
GlobeNewswire 2021-12-29 Aptose to Participate in Two Biotech Events in January 2022
GlobeNewswire 2021-12-20 Aptose Provides Update on APTO-253 Program
GlobeNewswire 2021-12-13 HM43239 Demonstrates Durable Clinical Benefit in Acute Myeloid Leukemia
GlobeNewswire 2021-11-29 Aptose to Hold Corporate Update Monday, December 13th
GlobeNewswire 2021-11-22 Aptose to Present at the Piper Sandler 33rd Annual Healthcare Conference
GlobeNewswire 2021-11-11 Aptose Reports Results for the Third Quarter 2021
GlobeNewswire 2021-11-04 Aptose Clinical Data to be Presented at the 2021 ASH Annual Meeting